PBPK Predictive Modeling Services

Source: Lonza
Scientist Using Tablet In Lab GettyImages-1354172577

Early identification of potential absorption risks, such as poor solubility, dissolution, and/or permeability, is critical for rapid and efficient drug development. Upfront knowledge of absorption risks can trigger early assessment of solid form and formulation strategies designed to achieve target bioperformance. Lonza's dedicated Physiologically-Based Pharmacokinetic (PBPK) modeling experts work with your compound to:

  • Identify absorption risks such as solubility, dissolution rate, and permeability
  • Forecast fraction absorbed in preclinical and clinical species over a range of doses
  • Predict the likelihood of food-drug or pH-dependent drug-drug interactions

Lonza's PBPK modeling services are designed to de-risk your drug development program. Using established ADMET Predictor® and GastroPlus® modeling software, linked with an expansive set of in-vitro testing, we can identify absorption risks and select technologies to meet target bioperformance.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader